The store will not work correctly when cookies are disabled.
1-(4-((2,4-dimethylbenzyl)(methyl)amino)butyl)-3,4-dihydroquinolin-2(1H)-one
ID: ALA4533030
PubChem CID: 155547794
Max Phase: Preclinical
Molecular Formula: C23H30N2O
Molecular Weight: 350.51
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccc(CN(C)CCCCN2C(=O)CCc3ccccc32)c(C)c1
Standard InChI: InChI=1S/C23H30N2O/c1-18-10-11-21(19(2)16-18)17-24(3)14-6-7-15-25-22-9-5-4-8-20(22)12-13-23(25)26/h4-5,8-11,16H,6-7,12-15,17H2,1-3H3
Standard InChI Key: XSXHPHKBHYXVMP-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
26.0928 -27.5367 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.7981 -27.1200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5099 -27.5215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2134 -27.1058 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9252 -27.5073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6288 -27.0917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.3835 -27.1337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6803 -27.5469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6843 -28.3664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3776 -26.3165 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.1070 -28.3561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3987 -28.7690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4030 -29.5869 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1149 -29.9931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8240 -29.5752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8161 -28.7586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3406 -27.4932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6206 -26.2745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3487 -28.3103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6436 -28.7223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6515 -29.5386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3638 -29.9410 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0697 -29.5209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0583 -28.7059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9329 -28.3189 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3730 -30.7581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
1 7 1 0
1 11 1 0
7 8 1 0
8 9 1 0
9 12 1 0
7 10 2 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
6 17 1 0
6 18 1 0
17 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
20 25 1 0
22 26 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 350.51 | Molecular Weight (Monoisotopic): 350.2358 | AlogP: 4.49 | #Rotatable Bonds: 7 |
Polar Surface Area: 23.55 | Molecular Species: BASE | HBA: 2 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 9.27 | CX LogP: 4.73 | CX LogD: 2.87 |
Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.69 | Np Likeness Score: -1.40 |
References
1. Zampieri D, Fortuna S, Calabretti A, Romano M, Menegazzi R, Schepmann D, Wünsch B, Collina S, Zanon D, Mamolo MG.. (2019) Discovery of new potent dual sigma receptor/GluN2b ligands with antioxidant property as neuroprotective agents., 180 [PMID:31319263] [10.1016/j.ejmech.2019.07.012] |